Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Ruzicka

Showing results (71-80 of 314) with videos related to

Pageof 32
Sort By:
Dermatology (Basel, Switzerland)|May 29, 2003
Papulonodular mucinosis associated with subacute cutaneous lupus erythematosusMonika Sonntag, Percy Lehmann, Mosaad Megahed, et al.
Journal of the American Academy of Dermatology|May 17, 2011
Erythema marginatum hemorrhagicum: a unique cutaneous side effect of sorafenibKatharina Rübsam, Michael J Flaig, Thomas Ruzicka, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 22, 2011
New developments in fluorescence diagnosticsJuraj Hegyi, Vladimir Hegyi, Thomas Ruzicka, et al.
Archives of Dermatological Research|March 12, 2010
Control of cutaneous antimicrobial peptides by vitamin D3Yvonne Dombrowski, Mark Peric, Sarah Koglin, et al.
Archives of Dermatology|June 22, 2005
Mondor disease associated with physical strain: report of 2 casesCarolina Talhari, Renz Mang, Mosaad Megahed, et al.
International Journal of Dermatology|January 14, 2017
Proximal onycholysis as a complication of hand, foot, and mouth diseaseIşın Sinem Bağcı, Michael J Flaig, Thomas Ruzicka, et al.
Dermatology (Basel, Switzerland)|August 16, 2003
Lupus erythematosus tumidus in childhood. Report of 3 patientsMonika Sonntag, Percy Lehmann, Mosaad Megahed, et al.
Journal of Clinical Pathology|April 15, 2011
Progressive macular hypomelanosis Guillet-Hélénon: structural and immunohistochemical findingsAlexander Vasilevic Kuznetsov, Michael Joseph Flaig, Thomas Ruzicka, et al.
Lancet (London, England)|March 16, 2005
Long-standing oral ulcersCarolina Talhari, Wolfgang Angerstein, Jürgen Becker, et al.
The Journal of Dermatology|June 6, 2019
Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II studyRyosuke Mihara, Kenji Kabashima, Masutaka Furue, et al.
Pageof 32

Showing results (71-80 of 314) with videos related to

Sort By:
Pageof 32
Dermatology (Basel, Switzerland)|May 29, 2003
Papulonodular mucinosis associated with subacute cutaneous lupus erythematosusMonika Sonntag, Percy Lehmann, Mosaad Megahed, et al.
Journal of the American Academy of Dermatology|May 17, 2011
Erythema marginatum hemorrhagicum: a unique cutaneous side effect of sorafenibKatharina Rübsam, Michael J Flaig, Thomas Ruzicka, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 22, 2011
New developments in fluorescence diagnosticsJuraj Hegyi, Vladimir Hegyi, Thomas Ruzicka, et al.
Archives of Dermatological Research|March 12, 2010
Control of cutaneous antimicrobial peptides by vitamin D3Yvonne Dombrowski, Mark Peric, Sarah Koglin, et al.
Archives of Dermatology|June 22, 2005
Mondor disease associated with physical strain: report of 2 casesCarolina Talhari, Renz Mang, Mosaad Megahed, et al.
International Journal of Dermatology|January 14, 2017
Proximal onycholysis as a complication of hand, foot, and mouth diseaseIşın Sinem Bağcı, Michael J Flaig, Thomas Ruzicka, et al.
Dermatology (Basel, Switzerland)|August 16, 2003
Lupus erythematosus tumidus in childhood. Report of 3 patientsMonika Sonntag, Percy Lehmann, Mosaad Megahed, et al.
Journal of Clinical Pathology|April 15, 2011
Progressive macular hypomelanosis Guillet-Hélénon: structural and immunohistochemical findingsAlexander Vasilevic Kuznetsov, Michael Joseph Flaig, Thomas Ruzicka, et al.
Lancet (London, England)|March 16, 2005
Long-standing oral ulcersCarolina Talhari, Wolfgang Angerstein, Jürgen Becker, et al.
The Journal of Dermatology|June 6, 2019
Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II studyRyosuke Mihara, Kenji Kabashima, Masutaka Furue, et al.
Pageof 32